[ad_1]
A three-part purchase will allow for the purchase of 300,000 rapid antigen test units. A total of 43 suppliers submitted their offers.
Proposals are currently being examined: their compliance with technical specifications, qualification and other requirements. More detailed information will be posted at the end of this process.
“These tests are a modern and rapid diagnostic tool to determine whether a person is infected with the coronavirus. In Germany, for example, rapid antigen tests are already in use and have proven to be an effective tool in the fight against this virus. Insidious. From now on, they will also be used in Lithuania, according to the recommendations provided by the experts, “says Danas Bakša, Director of NVSPL, in a press release.
According to the head of the NVSPL, the objective of this acquisition was to reduce the risks of grievances and delays in the delivery of measures to become hostages of the situation. That is why it was divided into three equal parts and under identical conditions. If a provider decides to appeal the results, the rapid antigen tests acquired will be used in the next installment.
NVSPL recalls that these tests show a current active coronavirus infection in about half an hour. That is why they are so important when a quick response is required to see if a person is sick with coronavirus. They are particularly useful in the presence of outbreaks and outbreaks of this virus, where large volumes of samples need to be analyzed simultaneously and there is no time or capacity to analyze them using conventional PCR tests.
Rapid antigen tests can also be performed in symptomatic individuals no later than 5 days after the onset of symptoms and no later than 7 days after exposure, and in people who have been in contact and are potentially ill.
[ad_2]
